Probiotics Ameliorate Pioglitazone-associated Bone Loss in Diabetic Rats
Preprint
- 4 June 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Pioglitazone as a PPAR-g agonist are used for management of type 2 diabetes mellitus. Nevertheless, evidence showed that the therapeutic modulation of PPARg activity using Pioglitazone may be linked with bone mass reduction and fracture risk in type 2 diabetes mellitus patients. The objective of the current research was to inspect the preventive role of some types of probiotic strains including (Lactobacillus acidophilus, Lactobacillus reuteri, Lactobacillus casei, Bifidiobacterum longum and Bacillus coagulans) against pioglitazone-induced bone loss.Methods: Streptozotocin (60 mg/kg) was administered for diabetes induction. Diabetic rats were fed orally with pioglitazone (300 mg/kg) and probiotics (1×109 CFU/ml/day) alone and in combination of both for 4 weeks. Dual energy X-ray absorptiometry (DEXA) were used to asses BMD, BMC and area of the femur, spine and tibia at the experiment termination. Serum glucose, serum calcium, alkaline phosphatase, phosphorus, BUN, Creatinine, and urine calcium were also analyzed. Results: Administration of pioglitazone and probiotics alone and in combination significantly improved elevated blood glucose. Pioglitazone treatment significantly increased urinary calcium and BUN, and decreased ALP and creatinine. Co-treatment of probiotics with pioglitazone significantly decreased urinary calcium, creatinine and ALP. Pioglitazone showed detrimental effects on femur-BMD whereas treatment with probiotics remarkably ameliorated these effects. Among the tested probiotics Bifidiobacterum longum displayed the best protective effects on pioglitazone-induced bone loss in diabetic rats.Conclusion:This study suggests probiotic supplementation in diabetic patients on pioglitazone regime could be considering as a good strategy to ameliorate bone loss induced by pioglitazone.Keywords
All Related Versions
This publication has 35 references indexed in Scilit:
- The Effects of Soy Milk Enriched with Lactobacillus casei and Omega-3 on the Tibia and L5 Vertebra in Diabetic Rats: a Stereological StudyProbiotics and Antimicrobial Proteins, 2018
- Supportive Role of Probiotic Strains in Protecting Rats from Ovariectomy-Induced Cortical Bone LossProbiotics and Antimicrobial Proteins, 2018
- Lactobacillus acidophilus inhibits bone loss and increases bone heterogeneity in osteoporotic mice via modulating Treg-Th17 cell balanceBone Reports, 2018
- Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalkBiomedicine & Pharmacotherapy, 2017
- Effect of the antidiabetic agent pioglitazone on bone metabolism in ratsJournal of Pharmacological Sciences, 2017
- Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trialsMedicina, 2016
- Risk of fracture with thiazolidinediones: An updated meta-analysis of randomized clinical trialsBone, 2014
- Probiotics as potential biotherapeutics in the management of type 2 diabetes – prospects and perspectivesDiabetes/Metabolism Research and Reviews, 2013
- Supplementation of broccoli or Bifidobacterium longum–fermented broccoli suppresses serum lipid peroxidation and osteoclast differentiation on alveolar bone surface in rats fed a high-cholesterol dietNutrition Research, 2012
- Synthesis and utilisation of folate by yoghurt starter cultures and probiotic bacteriaInternational Journal of Food Microbiology, 2003